Skip to main content

Sermorelin CJC 1295 Protocol

Meaning

The Sermorelin CJC 1295 Protocol refers to a specific therapeutic regimen utilizing two synthetic peptides, Sermorelin and CJC 1295, which are Growth Hormone-Releasing Hormone (GHRH) analogues. This combination is administered to stimulate the pituitary gland’s pulsatile release of endogenous growth hormone (GH), a strategy often employed in anti-aging and regenerative medicine. The protocol aims to safely and physiologically elevate circulating GH and subsequent Insulin-like Growth Factor 1 (IGF-1) levels to support tissue repair, improve body composition, and enhance metabolic function without introducing exogenous GH.